Health Care & Life Sciences » Pharmaceuticals | Karolinska Development AB

Karolinska Development AB | Mutual Funds

Mutual Funds that own Karolinska Development AB

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Tredje AP Fonden
8,804,189
13.99%
4,125,689
0.02%
06/30/2017
Nordea Kapital
134,037
0.21%
-3,563
0.02%
01/31/2018
SEB Sverige Indexfond
77,341
0.12%
0
0%
12/31/2017
26,258
0.04%
0
0.01%
09/11/2018
Catella Sverige Index
11,000
0.02%
0
0.01%
08/31/2018
Handelsbanken Sverigefond Index
23
0%
-232,015
0%
08/31/2018
Handelsbanken Sverige Criteria
7
0%
-70,203
0%
08/31/2018
Nordea Avkastning
0
0%
-134,943
0%
03/31/2018

About Karolinska Development AB

View Profile
Address
Tomtebodavägen 23A
Solna AB 171 65
Sweden
Employees -
Website http://www.karolinskadevelopment.com
Updated 07/08/2019
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.